Gene: ZNF302
Official Full Name: zinc finger protein 302provided by HGNC
Gene Summary: This gene encodes a member of the zinc-finger protein family. The encoded protein contains seven C2H2-type zinc fingers and a KRAB domain, but its function has yet to be determined. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12318 | ZNF302 Knockout cell line (HeLa) | Human | ZNF302 | 1:3~1:6 | Negative | Online Inquiry |
KO12319 | ZNF302 Knockout cell line (HCT 116) | Human | ZNF302 | 1:2~1:4 | Negative | Online Inquiry |
KO12320 | ZNF302 Knockout cell line (HEK293) | Human | ZNF302 | 1:3~1:6 | Negative | Online Inquiry |
KO12321 | ZNF302 Knockout cell line (A549) | Human | ZNF302 | 1:3~1:4 | Negative | Online Inquiry |
ZNF302 Gene Knockout Cell Lines are genetically engineered cell lines in which the ZNF302 gene has been effectively disrupted or inactivated through the application of CRISPR-Cas9 technology. This innovative product serves as a crucial tool for researchers investigating the role of ZNF302 in cellular processes such as differentiation, proliferation, and disease mechanisms. The knockout of ZNF302 allows for the assessment of gene function, the exploration of phenotype alterations, and studies concerning cellular signaling pathways.
These cell lines operate on a well-characterized mechanism that employs the precision of CRISPR-Cas9 to create targeted gene edits, thereby enabling the analysis of loss-of-function phenotypes. This process facilitates the understanding of ZNF302's contribution to key biological processes and enables researchers to uncover the genotype-phenotype relationships in various pathological conditions.
The scientific importance of ZNF302 Gene Knockout Cell Lines cannot be understated; they hold vast applications in basic research, drug development, and translational medicine. With ZNF302 implicated in various diseases, including certain cancers and metabolic disorders, the knockout models aid in the discovery of potential therapeutic targets and biomarkers.
One of the primary advantages of using ZNF302 Gene Knockout Cell Lines is their specificity and efficiency compared to conventional knockout methods, which often yield off-target effects. Our engineered cell lines come fully validated and ready for high-throughput screening, significantly reducing research time and resources. Additionally, they are compatible with various culture systems and can be used in diverse experimental settings.
For researchers and clinicians alike, ZNF302 Gene Knockout Cell Lines represent a valuable resource for elucidating mechanisms of disease, discovering novel biomarkers, and advancing personalized medicine approaches. They provide a robust platform that contributes significantly to the evolving landscape of genetic research.
Our company prides itself on delivering high-quality genetic tools, backed by years of expertise in molecular biology and genomics, ensuring that our products meet rigorous scientific standards while driving innovation in research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.